Literature DB >> 1642220

An index of disease activity in patients with ulcerative colitis.

M Seo1, M Okada, T Yao, M Ueki, S Arima, M Okumura.   

Abstract

Quantification of disease severity was studied in 72 patients with ulcerative colitis, who had undergone total 85 clinical courses. We performed a multiple stepwise regression analysis, according to Truelove and Witts' classification, with disease severity as a dependent variable, and with 18 clinical, laboratory, and endoscopic parameters as independent variables. Results showed that disease severity in patients with ulcerative colitis is significantly influenced by five factors, namely, bloody stool, bowel movements, erythrocyte sedimentation rate (ESR), hemoglobin (Hb), and serum albumin. The activity index (AI) developed for ulcerative colitis is expressed as follows: AI = 60 x blood stool + 13 x bowel movements + 0.5 x ESR - 4 x HB - 15 x albumin + 200. Index values below 150, values between 150 and 220, and values above 220 nearly corresponded to mild, moderate, and severe disease, respectively, in Truelove and Witts' classification. We believe that the activity index is useful in evaluation of the effect of medical treatment in patients with ulcerative colitis. Its most important value will be in therapeutic trials.

Entities:  

Mesh:

Year:  1992        PMID: 1642220

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  70 in total

1.  Health-related quality of life after restorative proctocolectomy for ulcerative colitis: long-term results.

Authors:  Marco Scarpa; Imerio Angriman; Cesare Ruffolo; Antonio Ferronato; Lino Polese; Michela Barollo; Alessandro Martin; Giacomo C Sturniolo; Davide F D'Amico
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

2.  CCR4 is an up-regulated chemokine receptor of peripheral blood memory CD4+ T cells in Crohn's disease.

Authors:  Y Jo; T Matsumoto; S Yada; K Fujisawa; M Esaki; N Onai; K Matsushima; M Iida
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

3.  B1a lymphocytes in the rectal mucosa of ulcerative colitis patients.

Authors:  Lino Polese; Riccardo Boetto; Giuseppe De Franchis; Imerio Angriman; Andrea Porzionato; Lorenzo Norberto; Giacomo Carlo Sturniolo; Veronica Macchi; Raffaele De Caro; Stefano Merigliano
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

4.  Protein microarray analysis of disease activity in pediatric inflammatory bowel disease demonstrates elevated serum PLGF, IL-7, TGF-beta1, and IL-12p40 levels in Crohn's disease and ulcerative colitis patients in remission versus active disease.

Authors:  Howard A Kader; Velizar T Tchernev; Ebenezer Satyaraj; Serguei Lejnine; Gregory Kotler; Stephen F Kingsmore; Dhavalkumar D Patel
Journal:  Am J Gastroenterol       Date:  2005-02       Impact factor: 10.864

5.  Persistence of high CD40 and CD40L expression after restorative proctocolectomy for ulcerative colitis.

Authors:  Lino Polese; Imerio Angriman; De Franchis Giuseppe; Attilio Cecchetto; Giacomo-C Sturniolo; D'Inca Renata; Marco Scarpa; Cesare Ruffolo; Lorenzo Norberto; Mauro Frego; Davide-F D'Amico
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

6.  B1a lymphocytes in ulcerative colitis.

Authors:  Lino Polese; Giuseppe De Franchis; Marco Scarpa; Giacomo C Sturniolo; Cesare Ruffolo; Lorenzo Norberto; Mauro Frego; Davide F D'Amico; Imerio Angriman
Journal:  Int J Colorectal Dis       Date:  2007-03-20       Impact factor: 2.571

7.  Infiltration of CD19+ plasma cells with frequent labeling of Ki-67 in corticosteroid-resistant active ulcerative colitis.

Authors:  Yoshio Jinno; Haruo Ohtani; Shiro Nakamura; Motoji Oki; Kiyoshi Maeda; Kohei Fukushima; Hiroshi Nagura; Nobuhide Oshitani; Takayuki Matsumoto; Tetsuo Arakawa
Journal:  Virchows Arch       Date:  2006-01-25       Impact factor: 4.064

8.  Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis.

Authors:  Francesco Azzolini; Cristiano Pagnini; Lorenzo Camellini; Antonella Scarcelli; Alberto Merighi; Anna Maria Primerano; Angela Bertani; Aldo Antonioli; Federico Manenti; Gian Piero Rigo
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

9.  Histological and immunological features of appendix in patients with ulcerative colitis.

Authors:  Yukihiko Jo; Takayuki Matsumoto; Shinichiro Yada; Shotaro Nakamura; Takashi Yao; Masayuki Hotokezaka; Ryuichi Mibu; Mitsuo Iida
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

Review 10.  Severe ulcerative colitis: at what point should we define resistance to steroids?

Authors:  Maria Esteve; Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.